Exicure, Inc., a biotechnology company based in Chicago, Illinois, has announced a Special Meeting of Stockholders to be held virtually on August 15, 2024. The primary agenda for the meeting is to seek approval for an amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock. The proposed reverse stock split ratio ranges from 1-for-2 to 1-for-15, with the exact ratio to be determined at the discretion of the Board of Directors. The reverse stock split is intended to comply with Nasdaq's minimum bid price requirement, as the company's stock price has previously fallen below the $1.00 threshold. Exicure received a notice from Nasdaq on September 13, 2023, regarding non-compliance with...Show More

Exicure, Inc., a biotechnology company based in Chicago, Illinois, has announced a Special Meeting of Stockholders to be held virtually on August 15, 2024. The primary agenda for the meeting is to seek approval for an amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock. The proposed reverse stock split ratio ranges from 1-for-2 to 1-for-15, with the exact ratio to be determined at the discretion of the Board of Directors. The reverse stock split is intended to comply with Nasdaq's minimum bid price requirement, as the company's stock price has previously fallen below the $1.00 threshold. Exicure received a notice from Nasdaq on September 13, 2023, regarding non-compliance with the minimum bid price requirement and was given until September 9, 2024, to regain compliance. The company believes that the reverse stock split will improve the marketability and liquidity of its common stock. Stockholders of record as of July 26, 2024, will be entitled to vote at the Special Meeting. The company has also provided information on how stockholders can attend the virtual meeting and cast their votes.